Academic Journals Database
Disseminating quality controlled scientific knowledge

Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trial

ADD TO MY LIST
 
Author(s): Pérez-Losada Marcos | Posada David | Arenas Miguel | Jobes David | Sinangil Faruk | Berman Phillip | Crandall Keith

Journal: Retrovirology
ISSN 1742-4690

Volume: 6;
Issue: 1;
Start page: 67;
Date: 2009;
Original page

ABSTRACT
Abstract Differences in HIV-1 gp120 sequence variation were examined in North American volunteers who became infected during a phase III vaccine trial using the rgp120 vaccine. Molecular adaptation of the virus in vaccine and placebo recipients from different ethnic subgroups was compared by estimating the dN/dS ratios in viruses sampled from each individual using three different methods. ANOVA analyses detected significant differences in dN/dS ratios among races (P < 0.02). gp120 sequences from the black individuals showed higher mean dN/dS ratios for all estimators (1.24–1.45) than in other races (0.66–1.35), and several pairwise comparisons involving blacks remained significant (P < 0.05) after correction for multiple tests. In addition, black-placebo individuals showed significantly (P < 0.02) higher mean dN/dS ratios (1.3–1.66) than placebo individuals from the other races (0.65–1.56). These results suggest intrinsic differences among races in immune response and highlight the need for including multiple ethnicities in the design of future HIV-1 vaccine studies and trials.

Tango Rapperswil
Tango Rapperswil

     Affiliate Program